{ "article": { "LEGIARTI000019498036": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "R5121-209", "ETAT": "TRANSFERE", "TYPE": "AUTONOME", "DATE_FIN": "2012-11-09", "DATE_DEBUT": "2008-09-19" } }, "META_COMMUN": { "ID": "LEGIARTI000019498036", "URL": "article/LEGI/ARTI/00/00/19/49/80/LEGIARTI000019498036.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGIARTI000019495365", "@num": "3", "#text": "Décret n°2008-968\n du 16 septembre 2008 - art. 3", "@sens": "cible", "@cidtexte": "JORFTEXT000019494693", "@nortexte": "SJSP0813071D", "@numtexte": "2008-968", "@typelien": "CREE", "@naturetexte": "DECRET", "@datesignatexte": "2008-09-16" }, { "@id": "LEGIARTI000026589556", "@num": "3", "#text": "Décret n°2012-1236\n du 6 novembre 2012 - art. 3", "@sens": "cible", "@cidtexte": "JORFTEXT000026588856", "@nortexte": "AFSP1226229D", "@numtexte": "2012-1236", "@typelien": "TRANSFERE", "@naturetexte": "DECRET", "@datesignatexte": "2012-11-06" }, { "@id": "LEGIARTI000026590222", "@num": "R5121-217", "#text": "Code de la santé publique - art. R5121-217 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CONCORDE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" } ] }, "CONTEXTE": { "TEXTE": { "TM": { "TM": { "TM": { "TM": { "TM": { "TM": { "TITRE_TM": [ { "@id": "LEGISCTA000019498038", "@fin": "2012-11-09", "#text": "Section 17 : Modalités d'application aux hôpitaux des armées et au centre de transfusion sanguine des armées.", "@debut": "2008-09-19" }, { "@id": "LEGISCTA000026592262", "@fin": "2999-01-01", "#text": "Section 17 : Conditions d'autorisation des médicaments de thérapie innovante préparés ponctuellement", "@debut": "2012-11-09" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006178649", "@fin": "2999-01-01", "#text": "Chapitre Ier : Dispositions générales", "@debut": "2004-08-08" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006161012", "@fin": "2999-01-01", "#text": "Titre II : Médicaments à usage humain", "@debut": "2004-08-08" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006145489", "@fin": "2999-01-01", "#text": "Livre Ier : Produits pharmaceutiques", "@debut": "2004-07-29" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006132399", "@fin": "2999-01-01", "#text": "Cinquième partie : Produits de santé", "@debut": "2004-07-29" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006112927", "@fin": "2999-01-01", "#text": "Partie réglementaire", "@debut": "2000-12-23" } ] }, "@cid": "LEGITEXT000006072665", "@nature": "CODE", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Code de la santé publique", "@debut": "1953-10-07", "@id_txt": "LEGITEXT000006072665", "@c_titre_court": "Code de la santé publique" } ], "@date_publi": "2999-01-01", "@date_signature": "2999-01-01" } }, "VERSIONS": { "VERSION": [ { "@etat": "TRANSFERE", "LIEN_ART": { "@id": "LEGIARTI000019498036", "@fin": "2012-11-09", "@num": "R5121-209", "@etat": "TRANSFERE", "@debut": "2008-09-19", "@origine": "LEGI" } }, { "@etat": "MODIFIE", "LIEN_ART": { "@id": "LEGIARTI000026592257", "@fin": "2022-02-19", "@num": "R5121-209", "@etat": "MODIFIE", "@debut": "2012-11-09", "@origine": "LEGI" } }, { "@etat": "VIGUEUR", "LIEN_ART": { "@id": "LEGIARTI000045187742", "@fin": "2999-01-01", "@num": "R5121-209", "@etat": "VIGUEUR", "@debut": "2022-02-19", "@origine": "LEGI" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "

Pour l'application des dispositions du présent chapitre, les hôpitaux des armées et le centre de transfusion sanguine des armées sont regardés respectivement comme des établissements de santé et comme un établissement de transfusion sanguine.

" } }, "LEGIARTI000019495365": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "3", "TYPE": "ENTIEREMENT_MODIF", "DATE_FIN": "2999-01-01", "DATE_DEBUT": "2999-01-01" } }, "META_COMMUN": { "ID": "LEGIARTI000019495365", "URL": "article/LEGI/ARTI/00/00/19/49/53/LEGIARTI000019495365.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGISCTA000019498049", "#text": "Code de la santé publique - Section 16 : Conditions générales d'autorisatio... (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGISCTA000019498038", "#text": "Code de la santé publique - Section 17 : Modalités d'application aux hôpita... (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000019498044", "@num": "R5121-207", "#text": "Code de la santé publique - art. R5121-207 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000019498040", "@num": "R5121-208", "#text": "Code de la santé publique - art. R5121-208 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000019498036", "@num": "R5121-209", "#text": "Code de la santé publique - art. R5121-209 (T)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000019498033", "@num": "R5124-16", "#text": "Code de la santé publique - art. R5124-16 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" } ] }, "CONTEXTE": { "TEXTE": { "@cid": "JORFTEXT000019494693", "@nor": "SJSP0813071D", "@num": "2008-968", "@nature": "DECRET", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Décret n° 2008-968 du 16 septembre 2008 relatif aux conditions d'autorisation des activités portant sur les tissus et leurs dérivés, les préparations de thérapie cellulaire, de thérapie génique et de thérapie cellulaire xénogénique, et aux conditions d'autorisation de ces produits", "@debut": "2999-01-01", "@id_txt": "JORFTEXT000019494693", "@c_titre_court": "Décret n°2008-968 du 16 septembre 2008" }, { "@fin": "2999-01-01", "#text": "Décret n° 2008-968 du 16 septembre 2008 relatif aux conditions d'autorisation des activités portant sur les tissus et leurs dérivés, les préparations de thérapie cellulaire, de thérapie génique et de thérapie cellulaire xénogénique, et aux conditions d'autorisation de ces produits", "@debut": "2008-09-19", "@id_txt": "LEGITEXT000019495356", "@c_titre_court": "Décret n°2008-968 du 16 septembre 2008" } ], "@ministere": "Ministère de la santé, de la jeunesse, des sports et de la vie associative", "@date_publi": "2008-09-18", "@date_signature": "2008-09-16" } }, "VERSIONS": { "VERSION": [ { "LIEN_ART": { "@id": "LEGIARTI000019495365", "@fin": "2999-01-01", "@num": "3", "@debut": "2999-01-01", "@origine": "LEGI" } }, { "LIEN_ART": { "@id": "JORFARTI000019494703", "@fin": "2999-01-01", "@num": "3", "@debut": "2999-01-01", "@origine": "JORF" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "
A modifié les dispositions suivantes :

- Code de la santé publique
Sct. Section 16 : Conditions générales d'autorisation des préparations de thérapie génique et des préparations de thérapie cellulaire xénogénique., Art. R5121-207, Art. R5121-208, Sct. Section 17 : Modalités d'application aux hôpitaux des armées et au centre de transfusion sanguine des armées., Art. R5121-209, Art. R5124-16\n
\n

\n
" } }, "LEGIARTI000026589556": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "3", "TYPE": "ENTIEREMENT_MODIF", "DATE_FIN": "2999-01-01", "DATE_DEBUT": "2999-01-01" } }, "META_COMMUN": { "ID": "LEGIARTI000026589556", "URL": "article/LEGI/ARTI/00/00/26/58/95/LEGIARTI000026589556.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGISCTA000026592262", "#text": "Code de la santé publique - Section 17 : Conditions d'autorisation des méd... (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGISCTA000026590174", "#text": "Code de la santé publique - Section 18 : Modalités d'application aux hôpit... (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026592257", "@num": "R5121-209", "#text": "Code de la santé publique - art. R5121-209 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000019498036", "@num": "R5121-209", "#text": "Code de la santé publique - art. R5121-209 (T)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "TRANSFERE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590484", "@num": "R5121-210", "#text": "Code de la santé publique - art. R5121-210 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590513", "@num": "R5121-211", "#text": "Code de la santé publique - art. R5121-211 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590516", "@num": "R5121-212", "#text": "Code de la santé publique - art. R5121-212 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590490", "@num": "R5121-213", "#text": "Code de la santé publique - art. R5121-213 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590521", "@num": "R5121-214", "#text": "Code de la santé publique - art. R5121-214 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590524", "@num": "R5121-215", "#text": "Code de la santé publique - art. R5121-215 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590497", "@num": "R5121-216", "#text": "Code de la santé publique - art. R5121-216 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590222", "@num": "R5121-217", "#text": "Code de la santé publique - art. R5121-217 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" } ] }, "CONTEXTE": { "TEXTE": { "@cid": "JORFTEXT000026588856", "@nor": "AFSP1226229D", "@num": "2012-1236", "@nature": "DECRET", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Décret n° 2012-1236 du 6 novembre 2012 relatif aux médicaments de thérapie innovante", "@debut": "2999-01-01", "@id_txt": "JORFTEXT000026588856", "@c_titre_court": "Décret n°2012-1236 du 6 novembre 2012" }, { "@fin": "2999-01-01", "#text": "Décret n° 2012-1236 du 6 novembre 2012 relatif aux médicaments de thérapie innovante", "@debut": "2012-11-09", "@id_txt": "LEGITEXT000026589537", "@c_titre_court": "Décret n°2012-1236 du 6 novembre 2012" } ], "@ministere": "Ministère des affaires sociales et de la santé", "@date_publi": "2012-11-08", "@date_signature": "2012-11-06", "@num_parution_jo": "0260" } }, "VERSIONS": { "VERSION": [ { "LIEN_ART": { "@id": "LEGIARTI000026589556", "@fin": "2999-01-01", "@num": "3", "@debut": "2999-01-01", "@origine": "LEGI" } }, { "LIEN_ART": { "@id": "JORFARTI000026588877", "@fin": "2999-01-01", "@num": "3", "@debut": "2999-01-01", "@origine": "JORF" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "
A modifié les dispositions suivantes :

- Code de la santé publique
Art. R5121-209, Art. R5121-217\n
\n

\n
\n
\n
\n
A modifié les dispositions suivantes :

- Code de la santé publique
Sct. Section 18 : Modalités d'application aux hôpitaux des armées et au centre de transfusion sanguine des armées., Sct. Section 17 : Conditions d'autorisation des médicaments de thérapie innovante préparés ponctuellement, Art. R5121-209\n
\n

\n
\n
A créé les dispositions suivantes :

- Code de la santé publique
\n Art. R5121-210, Art. R5121-211, Art. R5121-212, Art. R5121-213, Art. R5121-214, Art. R5121-215, Art. R5121-216\n
\n

\n
" } }, "LEGIARTI000026590222": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "R5121-217", "ETAT": "MODIFIE", "TYPE": "AUTONOME", "DATE_FIN": "2024-06-30", "DATE_DEBUT": "2012-11-09" } }, "META_COMMUN": { "ID": "LEGIARTI000026590222", "URL": "article/LEGI/ARTI/00/00/26/59/02/LEGIARTI000026590222.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGIARTI000026589556", "@num": "3", "#text": "Décret n°2012-1236\n du 6 novembre 2012 - art. 3", "@sens": "cible", "@cidtexte": "JORFTEXT000026588856", "@nortexte": "AFSP1226229D", "@numtexte": "2012-1236", "@typelien": "CREE", "@naturetexte": "DECRET", "@datesignatexte": "2012-11-06" }, { "@id": "LEGIARTI000019498036", "@num": "R5121-209", "#text": "Code de la santé publique - art. R5121-209 (T)", "@sens": "cible", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CONCORDE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" } ] }, "CONTEXTE": { "TEXTE": { "TM": { "TM": { "TM": { "TM": { "TM": { "TM": { "TITRE_TM": [ { "@id": "LEGISCTA000026590174", "@fin": "2024-06-30", "#text": "Section 18 : Modalités d'application aux hôpitaux des armées et au centre de transfusion sanguine des armées", "@debut": "2012-11-09" }, { "@id": "LEGISCTA000049852223", "@fin": "2999-01-01", "#text": "Section 18 : Préparations hospitalières spéciales", "@debut": "2024-06-30" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006178649", "@fin": "2999-01-01", "#text": "Chapitre Ier : Dispositions générales", "@debut": "2004-08-08" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006161012", "@fin": "2999-01-01", "#text": "Titre II : Médicaments à usage humain", "@debut": "2004-08-08" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006145489", "@fin": "2999-01-01", "#text": "Livre Ier : Produits pharmaceutiques", "@debut": "2004-07-29" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006132399", "@fin": "2999-01-01", "#text": "Cinquième partie : Produits de santé", "@debut": "2004-07-29" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006112927", "@fin": "2999-01-01", "#text": "Partie réglementaire", "@debut": "2000-12-23" } ] }, "@cid": "LEGITEXT000006072665", "@nature": "CODE", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Code de la santé publique", "@debut": "1953-10-07", "@id_txt": "LEGITEXT000006072665", "@c_titre_court": "Code de la santé publique" } ], "@date_publi": "2999-01-01", "@date_signature": "2999-01-01" } }, "VERSIONS": { "VERSION": [ { "@etat": "MODIFIE", "LIEN_ART": { "@id": "LEGIARTI000026590222", "@fin": "2024-06-30", "@num": "R5121-217", "@etat": "MODIFIE", "@debut": "2012-11-09", "@origine": "LEGI" } }, { "@etat": "VIGUEUR", "LIEN_ART": { "@id": "LEGIARTI000049852219", "@fin": "2999-01-01", "@num": "R5121-217", "@etat": "VIGUEUR", "@debut": "2024-06-30", "@origine": "LEGI" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "

" } } }, "article_lien": [ { "article_id": "LEGIARTI000026590222", "cible": true, "cidtexte": "LEGITEXT000006072665", "id": "LEGIARTI000019498036", "typelien": "CONCORDE" }, { "article_id": "LEGIARTI000026589556", "cible": false, "cidtexte": "LEGITEXT000006072665", "id": "LEGIARTI000019498036", "typelien": "TRANSFERE" }, { "article_id": "LEGIARTI000019495365", "cible": false, "cidtexte": "LEGITEXT000006072665", "id": "LEGIARTI000019498036", "typelien": "CREE" } ], "follow": [ "LIENS.LIEN[@sens=cible,@typelien=CREATION].@id" ], "id": "LEGIARTI000019498036", "liens_entrants": true }

Article R5121-209 AUTONOME TRANSFERE, en vigueur du 19/09/2008 au 09/11/2012 (Code de la santé publique)